Targeting heat shock proteins for immunotherapy in multiple myeloma: generation of myeloma-specific CTLs using dendritic cells pulsed with tumor-derived gp96
/in International Publications, Malignant Lymphoma /von 2005-12-15 / Clin. Cancer Res. 2005 Dec;11(24 Pt 1):8808-15Long-term outcomes in patients with metastatic melanoma vaccinated with melanoma peptide-pulsed CD34(+) progenitor-derived dendritic cells
/in International Publications, Malignant Melanoma /von 2005-12-06 / Cancer Immunol. Immunother. 2006 Oct;55(10):1209-18Vaccine strategies to treat lymphoproliferative disorders
/in Chronic Leukemia, Dendritic Cells, International Publications, Malignant Lymphoma, Multiple Myeloma /von 2005-12-01 / Pathology 2005 Dec;37(6):534-50Dendritic cell immunizations alone or combined with low doses of interleukin-2 induce specific immune responses in melanoma patients
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2005-12-01 / Clin. Exp. Immunol. 2005 Dec;142(3):555-68Virus-based therapies for colon cancer
/in International Publications, Newcastle Disease Virus /von 2005-12-01 / Expert Opin Biol Ther 2005 Dec;5(12):1627-33Thermal regulation of lymphocyte trafficking: hot spots of the immune response
/in Hyperthermia, International Publications /von 2005-12-01 / Int J Hyperthermia 2005 Dec;21(8):723-9Harnessing the immune system against human glioma
/in Glioblastoma, International Publications /von 2005-12-01 / Ann. N. Y. Acad. Sci. 2005 Dec;1062:13-21
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de